Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose metronomic oral paclitaxel with ritonavir in advanced cancer
NL-OMON44720Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of modrapac005 and ritonavir in cancer and Non-hematologic malignancy, sponsored by Netherlands Cancer Institute. Started Aug 2011; status: recruiting.
02
Drugs
modrapac005ritonavir
03
Conditions
cancerNon-hematologic malignancy
Beyond the preview
Go deeper on NL-OMON44720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44720.